Mobidiag’s rapid stool parasite identification Novodiag® and high-throughput gastrointestinal pathogen and antibiotic-resistance platform Amplidiag® are now available in Poland, Ukraine, Romania and Israel. The Finnish clinical diagnostics firm have made exclusive agreements with importers in these countries to facilitate the distribution of their products across Eastern Europe and the Middle East, with other country’s importers to follow suit.

Importing into Israel is Theranostica Ltd., who believe Mobidiag’s Novodiag® Stool Parasites qPCR and microarray platform will be “transformational for Israeli clinical laboratory customers”.

Importing into Romania is BIOgenetiX, who specialise in distribution services to laboratories of molecular and genetic biology, either diagnostic or research laboratories. ALAB Ltd will be equipping laboratories in Poland and Ukraine with Mobidiag technology.